Columbia’s Central Nervous System Metastases Clinic (CNSMets) was recently established to coordinate and advance the treatment of brain, leptomeningeal, skull base, spinal cord, and spine metastases.

A skilled surgeon and renowned researcher in locally advanced and metastatic breast cancer, Dr. Roshni Rao provides expertise in early stage breast cancer, innovative localization techniques, and tumescent mastectomy.

Weill Cornell Medicine has been awarded a five-year, $11.3 million Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute to improve the detection and treatment of aggressive prostate cancer (PCa).

A physician-scientist at NewYork-Presbyterian/Columbia has set her sights on applying the discoveries made in her lab to improve tissue healing and treatment for the many diseases that can affect the gut.

The DiLumen Endolumenal Interventional Platform (EIP) developed at NewYork-Presbyterian/Weill Cornell is paving the way for dramatic changes in the treatment of many intestinal diseases.

While the use of fecal material as a medical remedy dates back to the fourth century, usage waned. In recent years, fecal microbiota transplant to control multiple relapses of Clostridium difficile infections is rising.

The Pancreatic Cyst Surveillance Program at NewYork-Presbyterian/Columbia helps identify patients with pancreatic cysts who are at risk for developing cancer and those who are not.

Searching for approaches to address ongoing challenges, a number of studies and clinical trials are evaluating new approaches for neoadjuvant therapies and early phase clinical trials to assess novel therapeutic agents based on tumor genomics.